We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

VC-Backed Gossamer Bio Begins Trading After $276M IPO

Law360 (February 8, 2019, 4:36 PM EST) -- San Diego-based biopharmaceutical company Gossamer Bio started trading on the Nasdaq Global Select Market on Friday after the Latham & Watkins LLP-led company priced a $276 million initial public offering....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.